Clinical Significance of Pharmacokinetic Drug Interactions with Over-the-Counter (OTC) Drugs†

被引:0
作者
Peter K. Honig
Bradley K. Gillespie
机构
[1] Georgetown University,Department of Medicine
[2] Office of Clinical Pharmacology and Biopharmaceutics,Department of Medicine
[3] US Food and Drug Administration,undefined
[4] US Food and Drug Administration,undefined
来源
Clinical Pharmacokinetics | 1998年 / 35卷
关键词
Adis International Limited; Theophylline; Cimetidine; Ranitidine; Terfenadine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:167 / 171
页数:4
相关论文
共 94 条
[1]  
Newton G.D.(1997)New OTCs: a selected review J Am Pharm Assoc 37 166-76
[2]  
Pray W.S.(1995)Off the prescription pad and over the counter: the trend toward drug deregulation grows Can Med Assoc J 152 387-9
[3]  
Popovich N.G.(1992)Over-the-counter self-medication Drugs Aging 2 257-61
[4]  
Morgan P.P.(1992)Drug promotion in self-care and self-medication J Drug Issues 22 377-88
[5]  
Cohen L.(1994)Polypharmacy: pharmacokinetic perspectives Clin Pharmacokinet 26 85-90
[6]  
Mant A.(1985)Medication usage in an elderly population Med Care 23 165-70
[7]  
Whicker S.(1992)Polypharmacy in psychiatry: three case studies and methods for prevention DICP Ann Pharmacother 26 529-32
[8]  
Kwok Y.S.(1988)The ageing society Br J Hosp Med 39 112-8
[9]  
Sorofman B.(1960)Consumption of medicines on a working-class housing estate Br J Prev Soc Med 14 64-76
[10]  
Honig P.K.(1994)Specific requirements on content and format of labeling for human prescription drugs; revision of ‘pediatric use’ subsection in the labeling Federal Register 59 64240-50